Evaluation of Response to Stereotactic Body Radiation Therapy For Non-Small Cell Lung Cancer: PET Response Criteria in Solid Tumors (PERCIST) Versus Response Evaluation Criteria in Solid Tumors (RECIST)
Abstract:Background: Recommendations for surveillance after stereotactic body radiation therapy (SBRT) for early stage non–small cell lung cancer (NSCLC) are not well defined. Recently, PET response criteria in solid tumors (PERCIST) have been proposed as a new standardized method to assess radiotherapeutic response both quantitatively and metabolically. The aim of this study was to evaluate therapeutic response following Stereotactic Body Radiotherapy in early-stage Non-Small Cell Lung Cancer patients by comparing PER… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.